A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Insmed Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 4,902 shares of INSM stock, worth $358,581. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,902
Previous 4,477 9.49%
Holding current value
$358,581
Previous $299,000 19.4%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $26,350 - $33,579
425 Added 9.49%
4,902 $357,000
Q2 2024

Jul 23, 2024

BUY
$22.0 - $69.71 $98,494 - $312,091
4,477 New
4,477 $299,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.91B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.